// App-Quantinova.ai

72 : Effects of B‐Cell depleting therapy (Rituximab) on liver biochemistry in UDCA‐responsive patients: results from a randomised controlled trial of Rituximab in fatigued PBC patients (RitPBC).

Researchers

Presenter

  • Amardeep Khanna

Principal Investigators

  • Laura Jopson

  • Andrew M. Biamire

  • Julia L. Newton

  • Denise Howei

  • Andrew Bryant

  • Jennifer Wilkinson

  • Alison Steel

  • David Jones

Medical Centers

  • Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Institute of Health and Society, Newcastle upon Tyne, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved